SeaSpine Holdings Corporation logo
SeaSpine Holdings Corporation SPNE

Quarterly report 2022-Q3
added 11-03-2022

report update icon

SeaSpine Holdings Corporation Net Debt 2011-2026 | SPNE

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt SeaSpine Holdings Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-75 M -70.6 M -20.2 M -24.2 M -10.8 M -10.3 M -33.1 M -652 K -646 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-646 K -75 M -27.3 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Medical devices industry

Issuer Net Debt Price % 24h Market Cap Country
BioSig Technologies BioSig Technologies
BSGM
252 K - 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
38.7 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-230 M - - $ 3.31 B usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
16.5 M $ 0.55 -2.31 % $ 73.5 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
1.8 M - 14.99 % $ 929 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-32.4 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
14.2 M - -26.83 % $ 2.62 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
4.87 B $ 88.57 -0.65 % $ 18 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-3.31 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
6.46 M - -5.86 % $ 30.6 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
347 M $ 10.93 -5.12 % $ 1.64 B usaUSA
Conformis Conformis
CFMS
-26.2 M - - $ 16.4 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
73.7 M $ 0.4 4.21 % $ 41.1 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
-64.6 M - 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
2.62 M - -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-22.5 M - - $ 475 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
230 M - -4.14 % $ 702 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
802 M $ 34.58 -5.62 % $ 1.07 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-31.6 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.02 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-2.3 M - 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
-636 K - - $ 1.08 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
5.72 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
-4.95 M - - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.8 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
11.2 M $ 0.59 -1.18 % $ 32.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
-4.85 M $ 2.15 -5.29 % $ 3.36 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
-2.32 B $ 79.34 -3.36 % $ 46.4 B usaUSA
BIOLASE BIOLASE
BIOL
6.1 M - -13.19 % $ 166 K usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
1.64 B $ 11.2 -1.84 % $ 1.51 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
83.3 M $ 15.52 -5.08 % $ 364 M usaUSA
Invacare Corporation Invacare Corporation
IVC
299 M - - $ 24.7 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
-12.8 M - 10.0 % $ 610 K usaUSA
Myomo Myomo
MYO
-4.79 M $ 0.7 2.32 % $ 29.3 M usaUSA
Penumbra Penumbra
PEN
-152 M $ 335.1 -0.39 % $ 13 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
-433 M $ 50.13 -0.63 % $ 1.47 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
-31.6 M $ 1.17 -5.65 % $ 47.6 M usaUSA
Cutera Cutera
CUTR
-140 M - -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
-97.8 M - - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
-238 M - - $ 2.07 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
93.4 M - - $ 217 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
-5.5 M - -32.98 % $ 1.68 M usaUSA
STRATA Skin Sciences STRATA Skin Sciences
SSKN
2.4 M - - $ 6.6 M usaUSA
GBS GBS
GBS
-4.38 M - -0.57 % $ 7.12 M usaUSA
AVITA Medical AVITA Medical
RCEL
29.1 M $ 3.82 -1.04 % $ 106 M australiaAustralia
AxoGen AxoGen
AXGN
15.2 M $ 31.28 -3.01 % $ 1.44 B usaUSA
Delcath Systems Delcath Systems
DCTH
-42.5 M $ 8.97 -1.75 % $ 321 M usaUSA